Board Member at Reata Pharmaceuticals, Inc.
Dr Edwards has served as an Independent Non-Executive Director on our board of directors since April 2019. Dr Edwards has significant experience in investing and contributing to the development of biotech companies in both Europe and the US. Dr Edwards currently serves on the boards of Inozyme Pharma, Morphic Therapeutic and Reata Pharmaceuticals. Previously, he was Senior Partner at Novo Ventures from 2003-2020, and Corporate VP and Global Head of Drug Development for Novo Nordisk, where he led all aspects of pre-clinical and clinical drug development. Dr Edwards trained in physiology and medicine at the University of Manchester. He was elected a Member of the Royal College of Physicians, a Member with distinction of the Royal College of General Practitioners, a Fellow of the Faculty of Pharmaceutical Medicine and holds a MBA from the University of Warwick.
Source: Verona Pharma plc on 08/25/2023
By accessing ExecAtlas, you can view bios, network, connections and references of industry leading executives like Martin W. Edwards M.D.. More specifically, you'll be able to:
Access over 2,000,000 executive and board member profiles.
Example: Martin W. Edwards M.D.